LexDanaLexDanabeta
Inventor

John H. Hutchinson

Inventor
San Diego, CA, US

Overview

105→
Patents
1993–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 105 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds39%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
A61KPreparations for medical, dental or toiletry purposes24%
C07CAcyclic or carbocyclic compounds4%
C07KPeptides2%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium1%
C07BGeneral methods of organic chemistry0%
C07JSteroids0%
PatentTitleYear
11,072,585Fluorinated lysyl oxidase-like 2 inhibitors and uses thereof202111,058,676Quinolinone lysyl oxidase-like 2 inhibitors and uses thereof202110,766,860Lysyl oxidase-like 2 inhibitors and uses thereof202010,688,081Autotaxin inhibitor compounds202010,632,104Autotaxin inhibitors and uses thereof202010,597,367Metabotropic glutamate receptor negative allosteric modulators (NAMs) and uses thereof202010,588,900Quinolinone lysyl oxidase-like 2 inhibitors and uses thereof202010,570,094Fluorinated lysyl oxidase-like 2 inhibitors and uses thereof202010,150,732Fluorinated lysyl oxidase-like 2 inhibitors and uses thereof20189,999,615Autotaxin inhibitor compounds20189,951,026Heterocyclic vinyl autotaxin inhibitor compounds20189,926,318'Tetracyclic autotaxin inhibitors'20189,850,203Autotaxin inhibitor compounds20179,849,109Autotaxin inhibitors and uses thereof20179,714,240'Vinyl autotaxin inhibitor compounds'20179,624,182'Compounds as lysophosphatidic acid receptor antagonists'20179,468,628'Autotaxin inhibitor compounds'20169,334,261'Autotaxin inhibitor compounds'20169,272,990'Lysophosphatidic acid receptor antagonists and their use in the treatment fibrosis'20169,260,416'Heterocyclic autotaxin inhibitors and uses thereof'20169,193,710'Benzodiazepinones as modulators of metabotropic glutamate receptor functions and neurological uses thereof'20159,090,573'Compounds as lysophosphatidic acid receptor antagonists'20159,000,025'Autotaxin inhibitors and uses thereof'20158,841,295'5-lipoxygenase-activating protein (FLAP) inhibitors'20148,785,393'Ophthalmic pharmaceutical compositions of DP2 receptor antagonists'20148,710,081'5-lipoxygenase-activating protein (FLAP) inhibitors'20148,592,402'Compounds as lysophosphatidic acid receptor antagonists'20138,546,431'5-lipoxygenase-activating protein (FLAP) inhibitors'20138,524,748'Heteroalkyl biphenyl antagonists of prostaglandin D2 receptors'20138,501,959'Cycloalkane[B]indole antagonists of prostaglandin D2 receptors'20138,497,381'Antagonists of prostaglandin D2 receptors'20138,455,499'Alkyne antagonists of lysophosphatidic acid receptors'20138,440,707'Antagonists of lysophosphatidic acid receptors'20138,426,449'Aminoalkylphenyl antagonists of prostaglandin D2 receptors'20138,399,666'5-lipoxygenase-activating protein (FLAP) inhibitors'20138,383,654'Heterocyclic antagonists of prostaglandin D2 receptors'20138,378,107'Heteroaryl antagonists of prostaglandin D2 receptors'20138,362,044'N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors'20138,338,484'N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors'20128,273,780'Polycyclic antagonists of lysophosphatidic acid receptors'20128,247,602'Antagonists of prostaglandin D2 receptors'20128,242,145'Cyclic diaryl ether compounds as antagonists of prostaglandin D2 receptors'20128,217,066'Compounds as lysophosphatidic acid receptor antagonists'20128,168,678'N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors'20128,071,807'Antagonists of prostaglandin D2 receptors'20118,067,445'N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors'20118,058,300'Polycyclic antagonists of lysophosphatidic acid receptors'20118,049,015'Heteroaryl antagonists of prostaglandin D2 receptors'20118,048,902'Antagonists of lysophosphatidic acid receptors'20118,034,826'Cycloalkane[B]azaindole antagonists of prostaglandin D2 receptors'20117,977,359'5-lipdxygenase-activating protein (FLAP) inhibitors'20117,960,417'Benzazole potentiators of metabotropic glutamate receptors'20117,919,621'Tricyclic inhibitors of 5-lipoxygenase'20117,834,037'5-lipoxygenase-activating protein (FLAP) inhibitors'20107,795,274'5-lipoxygenase-activating protein (FLAP) inhibitors'20107,700,591'Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors'20107,629,467'Diphenyl substituted cycloalkanes, compositions containing such compounds and methods of use'20097,405,302'5-lipoxygenase-activating protein (FLAP) inhibitors'20087,153,862'αv integrin receptor antagonists'20067,109,191'Benzazepinone alpha vintegrin receptor antagonists'20066,916,810'αν integrin receptor antagonists'20056,784,190'Integrin receptor antagonists'20046,693,101'v integrin receptor antagonists'20046,645,974'Androgen receptor modulators and methods for use thereof'20036,515,023'Thrombin receptor antagonists'20036,472,403'V integrin receptor antagonists'20026,426,353' v integrin receptor antagonists'20026,387,903'Inhibitors of prenyl-protein transferase'20026,297,239'Inhibitors of prenyl-protein transferase'20016,248,756'Inhibitors of farnesyl-protein transferase'20016,090,944'Alkanoic acid derivatives as .alpha.v integrin receptor antagonists'20006,080,870'Biaryl substituted imidazole compounds useful as farnesyl-protein transferase inhibitors'20006,048,861'Integrin receptor antagonists'20006,017,926'Integrin receptor antagonists'20005,981,546'Integrin antagonists'19995,977,134'Inhibitors of farnesyl-protein transferase'19995,952,306'Integrin receptor antagonists'19995,925,651'Inhibitors of farnesyl-protein transferase'19995,922,883'Inhibitors of farnesyl-protein transferase'19995,889,023'Fibrinogen receptor antagonist'19995,852,045'Fibrinogen receptor antagonists'19985,789,421'Fibrinogen receptor antagonist'19985,719,162'Fibrinogen receptor antagonists'19985,719,144'Fibrinogen receptor antagonists'19985,665,723'Fibrinogen receptor antagonists'19975,652,257'Heterocycle-containing inhibitors of farnesyl-protein transferase'19975,585,359'Inhibitors of farnesyl-protein transferase'19965,424,320'Heteroaryl coumarins as inhibitors of leukotriene biosynthesis'19955,389,650'(Azaarylmethoxy)indoles as inhibitors of leukotriene biosynthesis'19955,380,850'(Quinolin-2-ylmethoxy)indoles as inhibitors of the biosynthesis of leukotrienes'19955,374,635'Furo[3,2-b]pyridines and thieno[3,2-b]pyridines as inhibitors of leukotriene biosynthesis'19945,360,815'Heteroaryl cinnamic acids as inhibitors of leukotriene biosynthesis'19945,321,033'Amorphous (quinolin-2-ylmethoxy)indole compounds useful for treating inflammatory diseases'19945,314,900'Aryl thiopyrano[2,3,4-C,D]indoles as inhibitors of leukotriene biosynthesis'19945,308,850'(Bicyclic-hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis'19945,290,798'(hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis'19945,281,720'Pyranylphenyl hydroxyalkylnaphthoic acids as inhibitors of leukotriene biosynthesis'19945,273,980'Bicyclic-azaarylmethoxy) indoles as inhibitors of leukotriene biosynthesis'19935,272,145'(Quinolin-2-ylmethoxy)indoles as inhibitors of the biosynthesis of leukotrienes'19935,254,567'Amorphous (quinolin-2-ylmethoxy)indole compounds which have useful pharmaceutical utility'19935,252,585'Fluorinated quinoline indoles as inhibitors of the biosynthesis of leukotrienes'19935,227,399'Pyranylphenyl naphthalene lactones as inhibitors of leukotriene biosynthesis'19935,204,344'(Quinolin-2-ylmethoxy)indoles as inhibitors of the biosynthesis of leukotrienes'19935,202,321'Thiopyrano[2,3,4-c,d]indoles as inhibitors of leukotriene biosynthesis'19935,190,968'(Polycyclic-arylmethoxy) indoles as inhibitors of leukotriene biosynthesis'1993

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1993–1995Patents assigned to MERCK FROSST CANADA INC (18)· patent assignee history
1993–1995Based in Montreal, CA· patent location history
1994–2006Based in Philadelphia, PA, US· patent location history
1996–2010Patents assigned to MERCK & CO INC (31)· patent assignee history
2003–2020Based in La Jolla, CA, US· patent location history
2008–2017Patents assigned to AMIRA PHARMACEUTICALS INC (18)· patent assignee history
2009–2010Based in LaJolla, CA, US· patent location history
2011–2016Patents assigned to HUTCHINSON JOHN HOWARD (25)· patent assignee history
2011–2014Patents assigned to PANMIRA PHARMACEUTICALS LLC (19)· patent assignee history
2011–2021Based in San Diego, CA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
MERCK & CO INC311996–2010
HUTCHINSON JOHN HOWARDself252011–2016
PANMIRA PHARMACEUTICALS LLC192011–2014
AMIRA PHARMACEUTICALS INC182008–2017
MERCK FROSST CANADA INC181993–1995
Locations
LocationPatentsSpan
San Diego, California, US392011–2021
Philadelphia, Pennsylvania, US291994–2006
La Jolla, California, US202003–2020
Montreal, CA151993–1995
LaJolla, California, US22009–2010